Singapore Government makes advance purchase of Sotrovimab to treat COVID-19
The Singapore Government has entered into an Advanced Purchased Agreement with GlaxoSmithKline Singapore and Vir Biotechnology for a supply of sotrovimab. The agreement was announced by GlaxoSmithKline Singapore and Vir Biotechnology in a statement on 30 June 2021. Sotrovimab is an investigational single-dose monoclonal antibody used for the treatment of patients with COVID-19 who do […]